Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss ...

Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Certain companies seem particularly relentless. Their ads don’t explicitly name the drugs they prescribe, but they don’t need to. Suggestive phrases like “doctor-supported weight loss” and “clinically ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

While the outcomes to weight loss drugs can be positive, Consumer Reports (CR) warns there are important considerations—especially for older adults—before starting these treatments.

Weight-loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and potential health benefits. While the outcomes can be positive, Consumer Reports ...

Novo Nordisk shares declined on Monday after the company reported that its next-generation weight-loss drug, CagriSema, ...